wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38641871-229EC5F6-A563-4F23-A4E2-51616E968F94
Q38641871-229EC5F6-A563-4F23-A4E2-51616E968F94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38641871-229EC5F6-A563-4F23-A4E2-51616E968F94
Bevacizumab in advanced lung cancer: state of the art.
P2860
Q38641871-229EC5F6-A563-4F23-A4E2-51616E968F94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38641871-229EC5F6-A563-4F23-A4E2-51616E968F94
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
28373ed7da6a89e3f9a0593c3d32f17ab6df42db
P2860
Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial.